% | $
Quotes you view appear here for quick access.

CryoLife Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • dlhild Aug 2, 2010 8:08 AM Flag

    Synergraft Aortic Valve, "can be a big deal"

    This valve may be great for mankind. However, it resides on the "tissue" side of CRY's product line. The margins there are low. Right now 51% of revenues come from tissue related sales. After the allocation of all fixed and variable costs the entire tissue business only generates less that $2 million in free cash flow. The remaining $15 million comes from BioGlue and HemoStase. Those are my WAG calculations anyway.

    I will believe its a big deal when it is FDA approved and more importantly when CRY shows me the free cash flow.

17.87+0.05(+0.28%)Sep 27 4:02 PMEDT